Christina D. Smolke is Professor, Associate Chair of Education, and W.M. Keck Foundation Faculty Scholar in the Department of Bioengineering and, by courtesy, Chemical Engineering at Stanford University. Christina’s academic research program develops foundational tools that drive transformative advances in our ability to engineering biology.
Professor Smolke's research program focuses on developing modular genetic platforms for programming information processing and control functions in living systems, resulting in transformative technologies for engineering, manipulating, and probing biological systems. She has pioneered the design and application of a broad class of RNA molecules, called RNA devices, that process and transmit user-specified input signals to targeted protein outputs, thereby linking molecular computation to gene expression. This technology has been extended to efficiently construct multi-input devices exhibiting various higher-order information processing functions, demonstrating combinatorial assembly of many information processing, transduction, and control devices from a smaller number of components. Her laboratory is applying these technologies to addressing key challenges in cellular therapeutics, targeted molecular therapies, and green biosynthesis strategies.
Christina is Co-founder and CEO of Antheia and Co-founder of Chimera Bioengineering. Antheia leverages advances in synthetic biology, genomics, informatics, and fermentation to transform how we make and discover many of our most important medicines. Her impact in advancing the frontiers of biotechnology has been recognized with numerous awards, including Chan Zuckerberg Biohub Investigator, Nature’s 10, AIMBE College of Fellows, NIH Director’s Pioneer Award, WTN Award in Biotechnology, and TR35 Award.
For more information on Dr. Smolke's research, please visit her website: http://smolkelab.weebly.com/